KHK4827
4827-KR001
Phase 3 small_molecule completed
Quick answer
KHK4827 for Moderate to Severe Plaque Psoriasis is a Phase 3 program (small_molecule) at KYOWA KIRIN AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- KYOWA KIRIN AUSTRALIA PTY LTD
- Indication
- Moderate to Severe Plaque Psoriasis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed